• STAT+: Is Philadelphia's biotech cluster faltering? Experts say no, even as funding dwindles

    29 days ago - By STAT

    Philadelphia is supposed to be a biotech hub. Two years ago, the city's life sciences startups brought in more than $450 million ; last year, they raised even more. A 2019 Philadelphia Magazine article proclaimed that “even when compared to Silicon Valley, Philadelphia has the most to offer,” and pointed out that more than 80 percent of leading life sciences companies have offices in the city.
    But Philly's growth appears to be slowing. Last November, the president of the Philadelphia Alliance for Capital & Technologies lamented that the city's biotech companies were “punching below weight”...
    Read more ...